Product Images Lorazepam
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Lorazepam NDC 64125-904 by Excellium Pharmaceutical Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This text contains information about a medication called Lorazepam, which is available in tablet form with a dosage of 0.5mg per tablet. The usual adult dosage is between 1-6mg per day and the tablets should be stored in a tight, light-resistant container at a temperature between 20°-25°C (68°-77°F). The prescription may contain additional instructions or warnings that can be seen on the package insert.*
This is a medication package containing Lorazepam USP, with a recommended dosage of 1-6 mg per day divided into doses. The tablets are to be stored at room temperature and dispensed in a light-resistant, child-resistant container. The NDC number is 64125-905-01.*
This appears to be a product description for a medication called Lorazepam USP, which comes in tablet form. The recommended adult dosage is up to six mg per day, taken in divided doses. The tablets should be stored at room temperature and in a light-resistant container with a child-resistant closure. The text also contains some random characters and symbols, which are not relevant to the product description.*
This is the chemical formula of a compound with the molecular weight of 321.16. The compound contains 15 carbon atoms, 10 hydrogen atoms, 2 nitrogen atoms, 2 chlorine atoms, and 2 oxygen atoms. However, the name of the compound is not provided.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.